UK markets close in 1 hour 33 minutes
  • FTSE 100

    7,526.96
    +52.94 (+0.71%)
     
  • FTSE 250

    19,226.80
    -65.55 (-0.34%)
     
  • AIM

    846.40
    -4.52 (-0.53%)
     
  • GBP/EUR

    1.1580
    +0.0016 (+0.14%)
     
  • GBP/USD

    1.1976
    +0.0011 (+0.09%)
     
  • BTC-GBP

    13,735.25
    +105.99 (+0.78%)
     
  • CMC Crypto 200

    388.68
    -0.04 (-0.01%)
     
  • S&P 500

    3,957.75
    -6.19 (-0.16%)
     
  • DOW

    33,778.21
    -71.25 (-0.21%)
     
  • CRUDE OIL

    78.73
    +1.49 (+1.93%)
     
  • GOLD FUTURES

    1,765.30
    +10.00 (+0.57%)
     
  • NIKKEI 225

    28,027.84
    -134.99 (-0.48%)
     
  • HANG SENG

    18,204.68
    +906.74 (+5.24%)
     
  • DAX

    14,385.68
    +2.32 (+0.02%)
     
  • CAC 40

    6,687.89
    +22.69 (+0.34%)
     

NASDAQ: SBFM

EQS-News: Sunshine Biopharma Inc.
NASDAQ: SBFM 👥 Enters Into A Collaboration Agreement For Its K1.1 Anticancer mRNA Project! 🔬
23.11.2022 / 17:20 CET/CEST
The issuer is solely responsible for the content of this announcement.

Contact Details

Christine Petraglia - TraDigital IR

+1 917-633-8980

investors@sunshinebiopharma.com

Company Website

https://sunshinebiopharma.com/


News Source: News Direct


23.11.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language:

English

Company:

Sunshine Biopharma Inc.

United States

ISIN:

US8677812054

EQS News ID:

1495061


 

End of News

EQS News Service

show this
show this